TriMas Co. (NASDAQ:TRS – Get Free Report) Director Herbert K. Parker acquired 6,000 shares of the stock in a transaction that occurred on Wednesday, May 8th. The stock was acquired at an average price of $26.27 per share, for a total transaction of $157,620.00. Following the transaction, the director now directly owns 51,157 shares of the company’s stock, valued at approximately $1,343,894.39. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
TriMas Price Performance
NASDAQ TRS traded up $0.20 during trading hours on Wednesday, reaching $26.45. 165,750 shares of the stock traded hands, compared to its average volume of 241,752. The stock has a 50 day simple moving average of $25.61 and a two-hundred day simple moving average of $25.15. TriMas Co. has a 1 year low of $22.59 and a 1 year high of $29.07. The company has a market cap of $1.08 billion, a price-to-earnings ratio of 27.06 and a beta of 0.71. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.73 and a quick ratio of 1.41.
TriMas (NASDAQ:TRS – Get Free Report) last announced its quarterly earnings data on Tuesday, April 30th. The industrial products company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. TriMas had a return on equity of 9.68% and a net margin of 4.48%. The firm had revenue of $227.10 million for the quarter, compared to analysts’ expectations of $220.60 million. During the same period last year, the firm earned $0.30 earnings per share. The company’s revenue for the quarter was up 5.4% compared to the same quarter last year. On average, analysts predict that TriMas Co. will post 1.92 EPS for the current fiscal year.
TriMas Announces Dividend
Wall Street Analysts Forecast Growth
Separately, BWS Financial restated a “buy” rating and set a $40.00 price target on shares of TriMas in a research report on Wednesday, May 1st.
View Our Latest Analysis on TriMas
Institutional Trading of TriMas
Several large investors have recently modified their holdings of TRS. SG Americas Securities LLC bought a new stake in shares of TriMas in the fourth quarter worth about $205,000. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of TriMas by 31.4% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,089 shares of the industrial products company’s stock worth $225,000 after purchasing an additional 2,173 shares during the last quarter. Quantbot Technologies LP grew its stake in shares of TriMas by 5.7% in the first quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company’s stock worth $239,000 after purchasing an additional 478 shares during the last quarter. Inspire Investing LLC bought a new stake in shares of TriMas in the third quarter worth about $308,000. Finally, Handelsbanken Fonder AB grew its stake in shares of TriMas by 19.8% in the fourth quarter. Handelsbanken Fonder AB now owns 15,095 shares of the industrial products company’s stock worth $382,000 after purchasing an additional 2,500 shares during the last quarter. 99.42% of the stock is owned by institutional investors.
TriMas Company Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Stories
- Five stocks we like better than TriMas
- Why Invest in Biotech Stocks
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Canadian Penny Stocks: Can They Make You Rich?
- Generac Powers Ahead on the Electrification Mega-Trend
- Stock Analyst Ratings and Canadian Analyst Ratings
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.